CUSIP: 37185R208
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SPON ADR 150SHS
-
Total 13F shares
-
1,832,053
-
Share change
-
-324,346
-
Total reported value
-
$1,649,000
-
Price per share
-
$0.90
-
Number of holders
-
13
-
Value change
-
-$301,423
-
Number of buys
-
7
-
Number of sells
-
4
Quarterly Holders Quick Answers
What is CUSIP 37185R208?
CUSIP 37185R208 identifies GENE - GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2017
-
Previous quarter:
Q1 2017
Recent filing periods for CUSIP 37185R208:
Institutional Holders of GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) as of Q2 2017
As of 30 Jun 2017,
GENETIC TECHNOLOGIES LTD - SPON ADR 150SHS (GENE) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,832,053 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu KCG Holdings LLC, BANK OF AMERICA CORP /DE/, SABBY MANAGEMENT, LLC, Alpine Group USVI, LLC, Alpine Global Management, LLC, CITADEL ADVISORS LLC, UBS Group AG, and Acrospire Investment Management LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.